Abstract
Purpose
The purpose of this study was to assess the use of 18F-FDG PET/CT scans for detecting distant metastases in patients with recurrent head and neck squamous cell carcinoma (HNSCC) and investigate the treatment and survival of patients with recurrence.
Methods
In this retrospective study, consecutive head and neck cancer patients referred for FDG PET/CT scan between 2012 and 2014 were included. Patient records were reviewed and only patients with recurrence of HNSCC were enrolled for further analysis. Information on distant metastases, surgery and survival was collected. A Kaplan–Meier analysis was used to report survival.
Results
Overall 275 PET/CT scans were performed due to suspected recurrence, and in 166 scans (144 patients), recurrence of HNSCC was confirmed, making them eligible for further analysis. Distant metastases were revealed in 29.8% of the scans (n = 51) and the proportion of revealed metastases remained constant at approximately 30% each year. Although the number of performed scans increased twofold each year, there was no statistically significant change in the proportion of scans with distant metastasis (p = 0.55). The distant metastases were most often seen in the lungs (n = 44) and bone (n = 15). A few patients had widespread dissemination to other areas. Salvage surgery was performed following 81 of the 166 PET/CT scans. Seven of the patients who underwent salvage surgery had M-site oligo-metastases. Patients who underwent salvage surgery had a median survival of 22 months whereas patients not treated with salvage surgery had a median survival of 6 months. After 5 years, 21% of the patients selected for salvage surgery were alive.
Conclusions
Distant metastases occur frequently in patients with recurrent HNSCC disease and the proportion of revealed distant metastases remained the same (30%). Imaging with FDG PET/CT can be recommended in patients with recurrent HNSCC prior to putative salvage surgery.
Similar content being viewed by others
References
Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67(1):7–30. https://doi.org/10.3322/caac.21387
Haines G 3rd (2013) Pathology of head and neck cancers I: epithelial and related tumors. In: Head and neck cancer: current perspectives, advances, and challenges, pp 257–287
Marur S, Forastiere AA, Lanier WL, Jopke TL, Sankey KD, Smith NM (2016) Head and neck squamous cell carcinoma: update on epidemiology, diagnosis, and treatment. Mayo Clin Proc 91:386–396. https://doi.org/10.1016/j.mayocp.2015.12.017
Cooper JS, Pajak TF, Forastiere AA et al (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 350(19):1937–1944. https://doi.org/10.1056/NEJMoa032646
Tobias JS, Monson K, Gupta N et al (2010) Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial. Lancet Oncol 11(1):66–74. https://doi.org/10.1016/S1470-2045(09)70306-7
Chang J-H, Wu C-C, Sheng K, Yuan -Po, Wu ATH, Wu S-Y (2017) Locoregionally recurrent head and neck squamous cell carcinoma: incidence, survival, prognostic factors, and treatment outcomes. Oncotarget 8(33):55600–55612. https://www.impactjournals.com/oncotarget. Accessed 19 Feb 2018
Patel SN, Cohen MA, Givi B et al (2016) Salvage surgery for locally recurrent oropharyngeal cancer. Head Neck 38(S1):E658–E664. https://doi.org/10.1002/hed.24065
Zafereo ME, Hanasono MM, Rosenthal DI et al (2009) The role of salvage surgery in patients with recurrent squamous cell carcinoma of the oropharynx. Cancer 115(24):5723–5733. https://doi.org/10.1002/cncr.24595
Lonneux M, Hamoir M, Reychler H et al (2010) Positron emission tomography with [18F]Fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study. J Clin Oncol 28(7):1190–1195. https://doi.org/10.1200/JCO.2009.24.6298
Cacicedo J, Fernandez I, del Hoyo O et al (2015) Should PET/CT be implemented in the routine imaging work-up of locally advanced head and neck squamous cell carcinoma? A prospective analysis. Eur J Nucl Med Mol Imaging 42(9):1378–1389. https://doi.org/10.1007/s00259-015-3071-0
Johansen J, Buus S, Loft A et al (2008) Prospective study of 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor: results from the DAHANCA-13 study. Head Neck 30(4):471–478. https://doi.org/10.1002/hed.20734
Cacicedo J, Navarro A, del Hoyo O et al (2016) Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist. Br J Radiol 89(1067):20160217. https://doi.org/10.1259/bjr.20160217
Troost EGC, Schinagl DAX, Bussink J, Oyen WJG, Kaanders JHAM (2010) Clinical evidence on PET-CT for radiation therapy planning in head and neck tumours. Radiother Oncol 96(3):328–334. https://doi.org/10.1016/j.radonc.2010.07.017
Bentzen SM, Gregoire V (2011) Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription. Semin Radiat Oncol 21(2):101–110. https://doi.org/10.1016/j.semradonc.2010.10.001
Mehanna H, Wong W-L, McConkey CC et al (2016) PET-CT surveillance versus neck dissection in advanced head and neck cancer. N Engl J Med 374(15):1444–1454. https://doi.org/10.1056/NEJMoa1514493
https://www.sum.dk/Aktuelt/Publikationer/Healthcare-in-Denmark-dec-2016.aspx
Yoo J, Henderson S, Walker-Dilks C (2013) Evidence-based guideline recommendations on the use of positron emission tomography imaging in head and neck cancer. Clin Oncol 25:e33–e66. https://doi.org/10.1016/j.clon.2012.08.007
Wong WL, Ross P, Corcoran M (2013) Evidence-based guideline recommendations on the use of positron emission tomography imaging in head and neck cancer from ontario and guidelines in general-some observations. Clin Oncol 25:242–245. https://doi.org/10.1016/j.clon.2013.01.004
Fakhry N, Michel J, Colavolpe C, Varoquaux A, Dessi P, Giovanni A (2012) Screening for distant metastases before salvage surgery in patients with recurrent head and neck squamous cell carcinoma: a retrospective case series comparing thoraco-abdominal CT, positron emission tomography and abdominal ultrasound. Clin Otolaryngol 37(3):197–206. https://doi.org/10.1111/j.1749-4486.2012.02481.x
Yi JS, Kim JS, Lee JH et al (2012) 18 F-FDG PET/CT for detecting distant metastases in patients with recurrent head and neck squamous cell carcinoma. J Surg Oncol 106(6):708–712. https://doi.org/10.1002/jso.23185
Ryu IS, Roh J-L, Kim JS et al (2016) Impact of (18)F-FDG PET/CT staging on management and prognostic stratification in head and neck squamous cell carcinoma: a prospective observational study. Eur J Cancer 63:88–96. https://doi.org/10.1016/j.ejca.2016.05.002
Brouwer J, de Bree R, Hoekstra OS et al (2005) Screening for distant metastases in patients with head and neck cancer: is chest computed tomography sufficient? Laryngoscope 115(10):1813–1817. https://doi.org/10.1097/01.mlg.0000174954.51514.b7
Ng S-H, Chan S-C, Yen T-C et al (2010) Comprehensive imaging of residual/recurrent nasopharyngeal carcinoma using whole-body MRI at 3 T compared with FDG-PET-CT. Eur Radiol 20(9):2229–2240. https://doi.org/10.1007/s00330-010-1784-9
Gourin CG, Watts T, Williams HT, Patel VS, Bilodeau PA, Coleman TA (2009) Identification of distant metastases with PET-CT in patients with suspected recurrent head and neck cancer. Laryngoscope 119(4):703–706. https://doi.org/10.1002/lary.20118
Perlow A, Bui C, Shreve P, Sundgren PC, Teknos TN, Mukherji SK (2004) High incidence of chest malignancy detected by FDG PET in patients suspected of recurrent squamous cell carcinoma of the upper aerodigestive tract. J Comput Assist Tomogr 28(5):704–709. https://doi.org/10.1097/01.rct.0000135279.71388.f9
Rohde M, Nielsen AL, Johansen J et al (2017) Head-to-Head comparison of chest X-ray/head and neck MRI, chest CT/head and neck MRI, and 18F-FDG PET/CT for detection of distant metastases and synchronous cancer in oral, pharyngeal, and laryngeal cancer. J Nucl Med 58(12):1919–1924. https://doi.org/10.2967/jnumed.117.189704
Kim SY, Roh J-L, Yeo N-K et al (2007) Combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer. Ann Oncol Off J Eur Soc Med Oncol 18(10):1698–1703. https://doi.org/10.1093/annonc/mdm270
Xu G, Li J, Zuo X, Li C (2012) Comparison of whole body positron emission tomography (PET)/PET-computed tomography and conventional anatomic imaging for detecting distant malignancies in patients with head and neck cancer: a meta-analysis. Laryngoscope 122(9):1974–1978. https://doi.org/10.1002/lary.23409
Xu G-Z, Guan D-J, He Z-Y (2011) 18FDG-PET/CT for detecting distant metastases and second primary cancers in patients with head and neck cancer. A meta-analysis. Oral Oncol 47(7):560–565. https://doi.org/10.1016/j.oraloncology.2011.04.021
Gao S, Li S, Yang X, Tang Q (2014) Review 18 FDG PET-CT for distant metastases in patients with recurrent head and neck cancer after definitive treatment. A meta-analysis. Oral Oncol 50:163–167. https://doi.org/10.1016/j.oraloncology.2013.12.002
Goodwin WJ (2000) Salvage surgery for patients with recurrent squamous cell carcinoma of the upper aerodigestive tract: when do the ends justify the means? Laryngoscope 110(S93):1–18. https://doi.org/10.1097/00005537-200003001-00001
Guo T, Qualliotine JR, Ha PK et al (2015) Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer. Cancer 121(12):1977–1984. https://doi.org/10.1002/cncr.29323
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
Informed consent is not required for this study under Danish law, but the data collection was approved by the Danish Data Protection agency.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Nøhr, A., Gram, S.B., Charabi, B. et al. PET/CT prior to salvage surgery in recurrent head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 276, 2895–2902 (2019). https://doi.org/10.1007/s00405-019-05550-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-019-05550-1